Author/Authors :
Mao، نويسنده , , Jian-Hua and Wu، نويسنده , , Di and Perez-Losada، نويسنده , , Jesus and Jiang، نويسنده , , Tao-Sheng Li، نويسنده , , Qian and Neve، نويسنده , , Richard M. and Gray، نويسنده , , Joe W. and Cai، نويسنده , , Wei-Wen and Balmain، نويسنده , , Allan، نويسنده ,
Abstract :
Summary
rora-A kinase gene is amplified in a subset of human tumors and in radiation-induced lymphomas from p53 heterozygous mice. Normal tissues from p53−/− mice have increased Aurora-A protein levels, but lymphomas from these mice exhibit heterozygous deletions of Aurora-A and/or reduced protein expression. A similar correlation between low p53 levels and Aurora-A gene deletions and expression is found in human breast cancer cell lines. In vitro studies using mouse embryo fibroblasts demonstrate that inhibition of Aurora-A can have either positive or negative effects on cell growth as a function of p53 status. These data have implications for the design of approaches to targeted cancer therapy involving the crosstalk between Aurora-A kinase and p53 pathways.